Myeloma Treatment in Moradabad — Dr. Faran Naim, Hematology & Bone Marrow Transplant Specialist, Jigyasa Hospital
Persistent, unexplained bone pain — especially in the back or ribs — combined with fatigue and frequent infections is often written off as a sign of aging or overexertion. In some cases, however, it can be an early indicator of multiple myeloma, a cancer of the plasma cells that requires timely diagnosis and specialized treatment.
At Jigyasa Hospital, Dr. Faran Naim, our Hematology & Bone Marrow Transplant specialist, offers complete myeloma care in Moradabad — from initial diagnosis through chemotherapy, targeted therapy, stem cell transplant evaluation, and long-term maintenance — sparing patients from western Uttar Pradesh the added burden of travel to distant cities during an already difficult time.
What Is Multiple Myeloma?
Multiple myeloma is a cancer of plasma cells — a type of white blood cell normally responsible for producing antibodies that help fight infection. In myeloma, abnormal plasma cells multiply uncontrollably in the bone marrow, crowding out healthy blood-forming cells and producing large amounts of an abnormal protein (called monoclonal or M-protein) that doesn't function as a normal antibody.
This process damages bone, impairs normal blood cell production, and can affect kidney function, among other complications. Unlike leukemia, which mainly affects the blood, and lymphoma, which affects lymph nodes and lymphatic tissue, myeloma primarily affects the bone marrow and skeletal system, which explains why bone pain and fractures are such common presenting features.
Myeloma Exists on a Spectrum
MGUS (Monoclonal Gammopathy of Undetermined Significance)
A precursor condition that carries a small risk of progressing to active myeloma and is generally just monitored.
Smoldering Myeloma
An intermediate, asymptomatic stage with a higher progression risk than MGUS, also typically monitored closely rather than treated immediately.
Active (Symptomatic) Multiple Myeloma
When treatment is required, based on evidence of organ damage or specific high-risk features.
Symptoms of Multiple Myeloma
Myeloma symptoms are often remembered using the acronym CRAB, which stands for the key features that indicate active disease requiring treatment:
- • C — Calcium elevation: High blood calcium from bone breakdown, which can cause nausea, confusion, excessive thirst, and constipation
- • R — Renal (kidney) impairment: Reduced kidney function caused by abnormal proteins affecting kidney filtering
- • A — Anemia: Low red blood cell counts causing fatigue, paleness, and breathlessness
- • B — Bone disease: Bone pain, thinning (osteoporosis), lytic lesions (localized areas of bone destruction visible on imaging), and an increased risk of fractures, particularly in the spine, ribs, and pelvis
- • Frequent infections due to impaired normal antibody production
- • Unexplained weight loss
- • Numbness or weakness if spinal bone involvement affects nerves
- • Excessive thirst and urination related to elevated calcium
- • General fatigue and weakness
Because bone pain and fatigue are common complaints with many causes, myeloma is sometimes diagnosed only after symptoms have been present for a while — which is why abnormal findings on routine blood work, such as elevated total protein or anemia, are important clues that shouldn't be ignored.
How Multiple Myeloma Is Diagnosed
Dr. Naim uses a structured set of tests to confirm a myeloma diagnosis, assess its extent, and determine risk category:
Blood Tests
Complete blood count to check for anemia; kidney function tests; calcium levels; and serum protein electrophoresis with immunofixation to detect and characterize the abnormal M-protein, all processed through the hospital's NABL-accredited laboratory.
Serum Free Light Chain Assay
A sensitive blood test that measures light chain proteins produced by abnormal plasma cells, useful both for diagnosis and for monitoring treatment response.
24-Hour Urine Protein Studies
To detect Bence Jones proteins (light chains) excreted in urine, which can also affect kidney function.
Bone Marrow Aspiration and Biopsy
Confirms the percentage of abnormal plasma cells in the marrow, which is central to diagnosis, and allows for cytogenetic and molecular testing to assess risk features.
Imaging Studies
Whole-body low-dose CT, MRI, or PET-CT scans are used to detect lytic bone lesions, fractures, or areas of bone weakening that plain X-rays might miss.
Cytogenetic and FISH Testing
Performed on bone marrow samples to identify specific genetic abnormalities within the myeloma cells, which help classify the disease into standard-risk or high-risk categories and guide treatment intensity.
Staging
The Revised International Staging System (R-ISS) combines blood test results (beta-2 microglobulin, albumin, lactate dehydrogenase) with cytogenetic risk features to classify myeloma into stage I, II, or III, helping predict prognosis and inform treatment planning.
Specialized Hematology Expertise in Moradabad
Dr. Naim's focused training in blood cancers and bone marrow transplantation brings a level of specialist care to the region that has traditionally required travel to major metro centers.
Reliable Diagnostics Under One Roof
Myeloma diagnosis depends on a combination of blood tests, bone marrow studies, and imaging. Jigyasa Hospital's NABL-accredited laboratory supports the accurate testing this diagnosis requires.
End-to-End Treatment Coordination
From initial workup through induction therapy, transplant evaluation and coordination, and long-term maintenance, Dr. Naim manages the full continuum of myeloma care, keeping patients close to their support system wherever possible.
24/7 Emergency Care
Myeloma patients can experience sudden complications such as fractures, severe infections, or kidney problems. Round-the-clock emergency services ensure these situations are addressed promptly.
Trusted Myeloma Care in Moradabad
Patients from Moradabad, Rampur, Sambhal, Amroha, Bijnor, and nearby districts choose Jigyasa Hospital for specialist myeloma care, NABL lab, PM-JAY empanelment, and comprehensive support.
Treatment Options for Multiple Myeloma
Myeloma treatment has advanced substantially in recent years, and Dr. Naim tailors the approach based on the patient's age, overall fitness, disease risk category, and transplant eligibility:
Induction Therapy
The initial treatment phase, typically combining several drug classes — such as proteasome inhibitors, immunomodulatory agents, and steroids — to reduce the myeloma burden before further treatment.
Autologous Stem Cell Transplant
For eligible patients, particularly those who are younger and fit, high-dose chemotherapy followed by reinfusion of the patient's own previously collected stem cells is a standard approach to deepen and extend remission. Dr. Naim evaluates transplant eligibility as part of the overall treatment plan and coordinates the transplant pathway, including collection, conditioning, and post-transplant recovery care.
Maintenance Therapy
After induction treatment (with or without transplant), long-term maintenance medication is often continued to help sustain remission and delay relapse.
Targeted and Immune-Based Therapies
Newer drug classes, including monoclonal antibodies, are increasingly used in both initial and relapsed myeloma treatment, often improving depth and duration of response.
Bone-Directed Therapy
Medications such as bisphosphonates or other bone-strengthening agents are commonly used to reduce fracture risk, manage bone pain, and slow further bone damage — an important part of care given how central bone involvement is to myeloma.
Supportive Care
Managing anemia, kidney function, infection risk, and pain is an ongoing part of myeloma care, alongside the primary anti-cancer treatment.
Treatment for Relapsed or Refractory Myeloma
Myeloma often recurs after a period of remission. Dr. Naim manages relapse with alternative drug combinations, and evaluates whether a second transplant or newer therapy options are appropriate.
Monitoring MGUS and Smoldering Myeloma
Not every patient found to have an abnormal protein needs treatment right away. Patients diagnosed with MGUS or smoldering myeloma are typically placed on a monitoring schedule — periodic blood tests and clinical review — to watch for signs of progression to active disease. This watchful approach avoids unnecessary treatment while ensuring that any progression is caught early.
Why Choose Jigyasa Hospital for Myeloma Care
A myeloma diagnosis is understandably frightening, but with modern treatment, many patients achieve years of good-quality remission. Jigyasa Hospital, located on Rampur Road near Miglani Cinema, Moradabad, offers comprehensive myeloma care under Dr. Faran Naim, keeping as much of the journey as possible close to the patient home and family.
- • Specialized Hematology Expertise in Moradabad: Dr. Naim's focused training in blood cancers and bone marrow transplantation brings a level of specialist care to the region that has traditionally required travel to major metro centers.
- • Reliable Diagnostics Under One Roof: Myeloma diagnosis depends on a combination of blood tests, bone marrow studies, and imaging. Jigyasa Hospital's NABL-accredited laboratory supports the accurate testing this diagnosis requires.
- • End-to-End Treatment Coordination: From initial workup through induction therapy, transplant evaluation and coordination, and long-term maintenance, Dr. Naim manages the full continuum of myeloma care, keeping patients close to their support system wherever possible.
- • Ayushman Bharat PM-JAY Empanelment: Myeloma treatment, particularly with newer therapies, can be costly over the long term. Jigyasa Hospital's empanelment under PM-JAY helps improve access to care for eligible patients.
- • 24/7 Emergency Care: Myeloma patients can experience sudden complications such as fractures, severe infections, or kidney problems. Round-the-clock emergency services ensure these situations are addressed promptly.
Living With Multiple Myeloma
While multiple myeloma is generally not considered curable in the way some other cancers are, it is often manageable as a long-term, chronic condition with modern treatment, and many patients achieve years of good-quality remission. Staying active as tolerated, following bone-health precautions to reduce fracture risk, keeping up with vaccinations to reduce infection risk, and maintaining regular follow-up with the hematology team all contribute to a better long-term course.
Book an Appointment with Dr. Faran Naim
Jigyasa Hospital offers specialist hematology and myeloma care under the guidance of Dr. Faran Naim. From accurate diagnosis and individualized treatment to supportive care and long-term follow-up, comprehensive cancer care is available close to home.
Near Miglani Cinema, Rampur Road, Moradabad 244001
Call Now
7900903333Frequently Asked Questions
What is the difference between MGUS, smoldering myeloma, and active myeloma?
MGUS is an early, low-risk precursor condition that rarely needs treatment. Smoldering myeloma is an intermediate stage with a higher chance of progressing to active disease. Active myeloma shows evidence of organ damage (the CRAB criteria) or high-risk features and requires treatment.
Is multiple myeloma curable?
Multiple myeloma is generally treated as a chronic, manageable condition rather than a curable one, though many patients achieve long periods of remission with modern combination therapies and, where appropriate, stem cell transplant.
Why does myeloma cause bone pain and fractures?
Abnormal plasma cells release substances that increase bone breakdown while suppressing new bone formation, leading to weakened bone, lytic lesions, and an increased risk of fractures, particularly in the spine, ribs, and pelvis.
Does every myeloma patient need a stem cell transplant?
No. Transplant eligibility depends on age, overall fitness, and other health factors. Eligible patients often benefit from autologous transplant as part of their initial treatment, but many patients are treated effectively with drug combinations alone, especially if they are older or have other health conditions.
What blood test results might suggest myeloma?
Elevated total protein with a normal or low albumin level, unexplained anemia, elevated calcium, or reduced kidney function on routine blood work can all be early clues that prompt further myeloma-specific testing.
How is myeloma different from leukemia or lymphoma?
Myeloma affects plasma cells in the bone marrow and primarily impacts bone and kidney health. Leukemia affects blood-forming cells more broadly, while lymphoma affects lymph nodes and lymphatic tissue. Each has distinct diagnostic tests and treatment approaches, though all fall under the broader hematology-oncology field.
What is maintenance therapy in myeloma?
Maintenance therapy is a lower-intensity, longer-term medication given after initial induction treatment (and transplant, if performed) to help sustain remission and delay disease progression.
When should I see a hematologist for suspected myeloma?
Persistent, unexplained bone pain, especially in the back or ribs, combined with fatigue, frequent infections, or abnormal blood test results such as anemia or elevated protein levels, warrants a hematology evaluation.
Why Patients Choose Us
- 24/7 Emergency & Trauma Care
- Top Specialist Doctors
- Modern ICU & Operation Theatres
- Transparent & Affordable Pricing
- Ayushman Bharat Empanelled
- Cashless Insurance Support
- Multispeciality Under One Roof
Our Location
Near Miglani Cinema,
Rampur Road,
Moradabad 244001